Since 1990 Mirabaud has offered a wide range of services for public and private companies. Its services include equity research, capital markets, corporate advisory as well as institutional brokerage.
We focus on certain key equity market segments with an ideas driven approach to deliver investment opportunities to clients.
Long Term Macro/Thematic ideas: Scanning global equities, fixed-income, currencies, commodities and alternative asset classes to assist our clients in correctly identifying the big picture and emerging trends.
Equities/Stock selection/Baskets: We express the above themes in long and short single stock selection and carefully curated Baskets. Our clients receive updates through our daily and weekly research products.
TMT (Technology, Media and Telecommunications): One of our core strengths lies in our global TMT sector coverage. Our TMT team, led by Neil Campling, offers daily and weekly updates alongside TMT focused baskets.
Strategy: Our "10 point checklist" notes are designed for Fund Managers and buy side Analysts looking for notes which can provide the most information possible on a stock in a condensed format, whilst assuming little prior knowledge of the stock. Long term trends in value creation, cash flow, capital allocation and much else are ticked off in our simple 10 point checklist format.
Our proprietary quant tool "Compass" assists our team in confirming existing, and generating new ideas.
The Mirabaud Compass screening tool analyses millions of data points and allows users to evaluate over 18,000 stocks globally for Valuation, Quality and Momentum.
The Mirabaud research team based in Madrid offers specialised insight into their home markets. The team covers 60 Spanish stocks with specific focus on small & mid cap names, including a top down Strategy Equity Research product focus on the Spanish market.
The team also organises roadshows and reverse-roadshows. Our Spanish researchers have been awarded Starmine awards for three years.
The product covers Swiss companies, focusing on small & mid cap.
In addition to the generalist analysts, the team comprises niche specialists in healthcare (pharma, med tech and biotech) and industrials providing valuable insight and ideas in these sectors.
The team focuses on fundamentals, competitive positioning and pipelines, and generates a balanced top down and bottom up product, which identifies mismatch between market cap and intrinsic value through cash flow modelling for longer-term investors. The team provides corporate access to clients through the organisation of roadshows and reverse-roadshows throughout the year.
Every day, our experts deliver fresh insights on trending topics, sectors and markets to help you stay ahead of the curve.